Filter posts

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

Oncology Innovation Has Produced Major Drop in Pediatric Cancer Deaths

One of the toughest parts of working in the biotechnology industry is the likelihood that …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …

When Surviving Cancer Hits Close to Home

It has been almost 20 years now, but I’ll never forget the feeling of shock …

Biopharma Companies Tackle Non-Communicable Diseases

Twenty-two leading biopharmaceutical companies, along with partners such as the World Bank and the Union …

A Poignant Election Day Comeback

On Election Day, a day of underdogs and upsets in American politics, Representative Mark DeSaulnier …

Scientists Open New Window into Pancreatic Cancer Research

For years, pancreatic cancer has been referred to as the “silent killer.” It is notoriously …

Is Immunotherapy the 4th Pillar of Oncology?

In contrast to the three traditional pillars of cancer treatment (surgery, radiotherapy, and chemotherapy), cancer …